Previous close | 186.00 |
Open | 187.00 |
Bid | 187.00 x 10000 |
Ask | 188.00 x 10000 |
Day's range | 187.00 - 187.00 |
52-week range | 167.72 - 212.00 |
Volume | |
Avg. volume | 4 |
Market cap | 15.86B |
Beta (5Y monthly) | 1.00 |
PE ratio (TTM) | 42.99 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.68 (1.44%) |
Ex-dividend date | 28 May 2024 |
1y target est | N/A |
Q1 2024 OPKO Health Inc Earnings Call
Key developments include a major asset sale and a focus on pharmaceutical innovation, despite a challenging financial quarter.
On April 29, 2024, Peter Wilkinson, Senior Vice President and Chief Accounting Officer at Laboratory Corp of America Holdings (NYSE:LH), sold 2,439 shares of the company.